United States · Telehealth platform · Compounded
Bliv review
Compounded semaglutide from $116/month with no calls, no video and no contract — from a company FDA wrote to in February 2026.
Overview
Bliv sells compounded semaglutide “as low as $116 per month” and compounded tirzepatide “as low as $199 per month”, both footnoted “based on plan structure and eligibility”, which is the usual signal that the headline number depends on buying several months at once. The pitch is friction: “No Phone Calls. No Video visit.” You complete an intake, a US-licensed provider reviews it, and approval typically follows within 24 hours if you are suitable.
It is unusually clear about the commitment, and in the customer’s favour: “No Contracts”, with “no long-term commitments or cancellation fees”. In a tier where twelve-month prepayment and early-termination fees are common, that is worth noting, and it is the main reason to consider this service.
What it does not do is carry a compounding disclaimer. There is no statement anywhere we could find that compounded medicines are not FDA-approved — the disclosure Alloy, Noom and MEDVi all manage. Bliv Wellness LLC was also a recipient of an FDA warning letter in February 2026, which is set out above.
Medications and supply
Both medications are described as compounded. The site names no pharmacy beyond “U.S. pharmacy”, gives no 503A or 503B designation, and carries no statement that compounded drugs are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide
- Compounded tirzepatide
How the service works
- Consultation
- Written intake only — “Complete a quick medical intake”, “securely reviewed by a U.S.-licensed provider”, with “No Phone Calls. No Video visit.” Approval typically within 24 hours where suitable.
- Eligibility
- Not stated in the sources we checked.
- Provider involvement
- A US-licensed provider reviews the intake and prescribes where appropriate. No named clinicians and no detail on follow-up.
- Lab requirements
- Not stated in the sources we checked.
- Pharmacy fulfilment
- Fulfilled by a “U.S. pharmacy”. None is named and neither 503A nor 503B status is given.
- Shipping
- Free shipping, “in discreet packaging, typically within 3–5 days”.
- Support services
- Phone and email support — 888-859-2882 and support@joinbliv.com.
What it costs
| Item | Published price | Notes |
|---|---|---|
| Compounded semaglutide | from $116 / month | “based on plan structure and eligibility” |
| Compounded tirzepatide | from $199 / month | Same footnote |
| Financing | from $29 / month | CareCredit at 24 months 0%, or Klarna — a way of spreading the cost, not a lower price |
- Membership fee
- None published.
- Medication fee
- Bundled into the monthly price.
- Insurance
- Not stated in the sources we checked.
- HSA / FSA
- HSA/FSA is listed as a payment option in the footer, without further explanation.
- Cancellation
- “No Contracts” — the site states “no long-term commitments or cancellation fees”.
- Refunds
- Not stated in the sources we checked.
Pros
- No contract, no long-term commitment and no cancellation fee, stated plainly — the opposite of the prepaid-year model much of this tier runs on.
- Among the cheaper compounded semaglutide entry prices we verified.
- Fully asynchronous, which suits people who will not book a video call.
- Phone support with a published number, which is rarer here than it should be.
Cons
- An FDA warning letter to Bliv Wellness LLC in February 2026.
- No compounding disclaimer at all — nothing telling you the medicine is not FDA-approved.
- No pharmacy named and no 503A or 503B status.
- No eligibility criteria, lab requirements or refund policy published.
- The entry price is conditional on “plan structure”, which is not explained before checkout.
Who it may suit
Someone who wants a cheap compounded start without signing up to a year. The no-contract terms are genuinely better than most of this tier. Weigh that against a company FDA has written to, and get the plan structure behind the $116 in writing first.
Limitations
- We could not retrieve the FDA warning letter itself, only its existence, reference and date.
- No eligibility, lab or refund detail is published, so none of it could be verified.
- The pharmacy is not named, so the supply chain could not be checked.
Questions
How much does Bliv cost?
Compounded semaglutide from $116 a month and tirzepatide from $199, both “based on plan structure and eligibility” — so the lowest number generally means committing to several months at once. Financing from $29 a month via CareCredit or Klarna spreads the cost rather than reducing it.
Is there a contract?
The site says no: “No Contracts”, with “no long-term commitments or cancellation fees”. That is a meaningful advantage over the prepaid annual plans common in this tier, particularly given the legal pressure on compounded supply.
Do I need a video call?
No. Bliv is written intake only — “No Phone Calls. No Video visit.” A US-licensed provider reviews your answers, usually within 24 hours. Whether that is a convenience or a shortfall depends on how much you want a clinician to see you.
Has Bliv been in trouble with the FDA?
FDA issued a warning letter to Bliv Wellness LLC dba Bliv on 20 February 2026, reference MARCS-CMS 721479, in its enforcement against telehealth companies over marketing of compounded GLP-1s. We could not retrieve the letter to see what it specifically cites.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.
- 01Bliv — medications, pricing, intake process, shipping and contract termsretrieved 2026-08-16
- 02Bliv — Terms and Conditionsretrieved 2026-08-16
- 03FDA warning letter — Bliv Wellness LLC dba Bliv, MARCS-CMS 721479, 20 February 2026 (cited from FDA’s index; fda.gov refused direct retrieval)retrieved 2026-08-16